EARS2 Gene Combined Oxidative Phosphorylation Deficiency Type 12 Genetic Test
Test Details
The EARS2 gene is associated with a condition called Combined Oxidative Phosphorylation Deficiency Type 12 (COXPD12). This condition is characterized by a deficiency in the production of adenosine triphosphate (ATP), which is the main source of energy for cells.
NGS Genetic Testing refers to Next-Generation Sequencing, a high-throughput DNA sequencing technology that allows for the rapid and efficient sequencing of large amounts of genetic material. In the context of COXPD12, NGS Genetic Testing can be used to analyze the EARS2 gene and identify any genetic variations or mutations that may be causing the condition.
By identifying specific genetic variations or mutations in the EARS2 gene, NGS Genetic Testing can help diagnose COXPD12 and provide important information about the underlying cause of the condition. This information can be used to guide treatment decisions, provide prognostic information, and inform genetic counseling for affected individuals and their families.
Test Name: EARS2 Gene Combined Oxidative Phosphorylation Deficiency Type 12 Genetic Test
Components:
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Metabolic Disorders
- Doctor: General Physician
- Test Department: Genetics
Pre Test Information
Clinical History of Patient who is going for EARS2 Gene Combined Oxidative Phosphorylation Deficiency Type 12 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Combined Oxidative Phosphorylation Deficiency Type 12.
Test Name | EARS2 Gene Combined oxidative phosphorylation deficiency type 12 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Metabolic Disorders |
Doctor | General Physician |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for EARS2 Gene Combined oxidative phosphorylation deficiency type 12 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Combined oxidative phosphorylation deficiency type 12 |
Test Details |
The EARS2 gene is associated with a condition called Combined Oxidative Phosphorylation Deficiency Type 12 (COXPD12). This condition is characterized by a deficiency in the production of adenosine triphosphate (ATP), which is the main source of energy for cells. NGS Genetic Testing refers to Next-Generation Sequencing, a high-throughput DNA sequencing technology that allows for the rapid and efficient sequencing of large amounts of genetic material. In the context of COXPD12, NGS Genetic Testing can be used to analyze the EARS2 gene and identify any genetic variations or mutations that may be causing the condition. By identifying specific genetic variations or mutations in the EARS2 gene, NGS Genetic Testing can help diagnose COXPD12 and provide important information about the underlying cause of the condition. This information can be used to guide treatment decisions, provide prognostic information, and inform genetic counseling for affected individuals and their families. |